טוען...

Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU

BACKGROUND: The exhaustive registry of COVID-19 cases in patients with IBD is a unique opportunity to learn how to deal with this infection, especially in reference to the management of immunosuppressive treatment, isolation measures or if the disease is more severe in IBD patients due to immunosupp...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	J Crohns Colitis
Main Authors:	Zabana Abdo, Y, Marín-Jiménez, I, Rodríguez-Lago, I, Ramírez Esteso, F, Meijilde, S, Ramos, L, Gomollón, F, Muñoz, F, Suris, G, Ortiz de Zárate, J, Huguet, J M, Llaó, J, García-Sepulcre, M, Sierra, M, Durà, M, Estrecha, S, Fuentes Coronel, A, Hinojosa, E, Olivan, L, Iglesias, E, Gutiérrez, A, Varela, P, Rull, N, Gilabert, P, Hernández-Camba, A, Brotons, A, Ginard, D, Sesé, E, Carpio, D, Aceituno, M, Cabriada, J L, González-Lama, Y, Jiménez, L, Chaparro, M, López-San Román, A, Alba, C, Plaza-Santos, R, Piqueras, M, Domènech, E, Esteve, M
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Oxford University Press 2021
נושאים:	Poster Presentations
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC8194955/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjab076.729
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Inflammatory Bowel Disease (IBD) and immunosuppression do not worsen the prognosis of COVID-19. Results from the ENEIDA Project of GETECCU

פריטים דומים